PascalFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Inhibiteur enzyme »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Inhibiteur < Inhibiteur enzyme < Inhibiteur monoamine oxidase B  Facettes :

List of bibliographic references indexed by Inhibiteur enzyme

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
002639 (2007) Brian N. Mathur [États-Unis] ; M. Diana Neely [États-Unis] ; Melanie Dyllick-Brenzinger [Canada] ; Anurag Tandon [Canada] ; Ariel Y. Deutch [États-Unis]Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration
002A70 (2005) Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada]Chymotrypsin‐like proteases contribute to human monocytic THP‐1 cell as well as human microglial neurotoxicity
002E96 (2003) W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada]Treatment of Parkinson's disease
003060 (2002) Andrew J. Thompson [Royaume-Uni] ; Colin J. Barrow [Canada]Protein conformational misfolding and amyloid formation: Characteristics of a new class of disorders that include Alzheimer's and Prion diseases
003096 (2002) Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada]Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity
003551 (2000) D. J. Chong [Canada] ; O. Suchowersky [Canada] ; C. Szumlanski [États-Unis] ; R. M. Weinshilboum [États-Unis] ; R. Brant [Canada] ; N. R. C. Campbell [Canada]The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's Disease
003836 (1999) J. Rivest [Canada] ; C. L. Barclay [Canada] ; O. Suchowersky [Canada]COMT inhibitors in Parkinson's disease
003946 (1998) Ali Samii [Canada] ; Shallen R. Letwin [Canada] ; Donald B. Calne [Canada]Prospects for new drug treatment in idiopathic parkinsonism
003C32 (1997) A. H. Rajput [Canada] ; W. Martin [Canada] ; M.-H. Saint-Hilaire [États-Unis] ; E. Dorflinger [États-Unis] ; S. Pedder [États-Unis]Tolcapone improves motor function in parkinsonian patients with the "wearing-off" phenomenon: A double-blind, placebo-controlled, multicenter trial
003C61 (1997) D. J. Doudet [Canada] ; G. L. Y. Chan [Canada] ; J. E. Holden [États-Unis] ; K. S. Morrison [Canada] ; R. J. Wyatt [États-Unis] ; T. J. Ruth [Canada]Effects of catechol-O-methyltransferase inhibition on the rates of uptake and reversibility of 6-fluoro-L-dopa trapping in MPTP-induced Parkinsonism in monkeys
003C73 (1997) R. Kakkar [Canada] ; R. V. S. Raju [Canada] ; A. H. Rajput [Canada] ; R. K. Sharma [Canada]Amantadine: an antiparkinsonian agent inhibits bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme
004201 (1994) E. Scarr [Canada] ; D. M. Wingerchuk [Canada] ; A. V. Juorio [Canada] ; I. A. Paterson [Canada]The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions
004296 (1994) B. P. Connop [Canada] ; N. G. Rolfe ; R. J. Boegman [Canada] ; K. Jhamandas [Canada] ; R. J. BeningerPotentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole
004985 (1990) N. R. C. Campbell ; D. Rankine ; A. E. Goodridge ; B. B. Hasinoff ; M. KaraSinemet-ferrous sulphate interaction in patients with Parkinson's disease
004B26 (1989) J. K. Tsui ; S. Ross ; K. Poulin ; J. Douglas ; D. Postnikoff ; S. Calne ; W. Woodward ; D. B. CalneThe effect of dietary protein on the efficacy of L-dopa: a double-blind study

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Inhibiteur enzyme" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Inhibiteur enzyme" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Inhibiteur enzyme
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022